Slow speed of the Next-Generation sequencing data analysis, compared to the latest high throughput sequencers such as HiSeq X system, using the current industry standard genome analysis pipeline, has been the major factor of data backlog which limits the real-time use of genomic data for precision medicine. This study demonstrates the DRAGEN Bio-IT Processor as a potential candidate to remove the "Big Data Bottleneck". DRAGEN TM accomplished the variant calling, for ~40× coverage WGS data in as low as ~30 minutes using a single command, achieving the over 50-fold data analysis speed while maintaining the similar or better variant calling accuracy than the standard GATK Best Practices workflow. This systematic comparison provides the faster and efficient NGS data analysis alternative to NGS-based healthcare industries and research institutes to meet the requirement for precision medicine based healthcare.
Introduction
With the emergence of the 2nd generation high throughput Next Generation Sequencing (NGS) platforms as well as accurate and consistent identification of the genomic variants, the use of the personal genome sequencing information for the diagnostic and prognostic purpose has become the reality [1] [2] . Furthermore, fast sequencing turnaround time and roughly $1000 NGS whole genome cost is encouraging more institutes and individuals to opt for NGS based personalized medicine [3] - [8] . However, the "Big Data Bottleneck" is still the largest obstacle to use the NGS-based precision medicine in the real time disease and healthcare management. For instance, high throughput NGS HiSeq X Ten System has around 18,000 humans' whole genome sequencing capacity at 30× genome coverage annually which translates into just ~30 -40-minute turnaround time for each genome sequencing. The most commonly used Genome Analysis Toolkit (GATK) best practice pipelines requires several hours to several days to analyze one human whole genome sequencing data, depending on the available processors. At commercial level, NGS-based data analysis time can be reduced significantly using the clusters of hundreds or thousands of CPUs. Also, several cloud-based solutions, such as GenomePilot by Appistry [9] , etc., to accelerate NGS-data analysis platform to speed-up the analysis has been introduced. However, this conventional cluster approach requires expensive computer system, maintenance and monitoring. Similarly, cloud-based platforms require massive data upload and download which is a limitation/burden for many research institutes and small to medium scale companies, especially in low bandwidth supported countries. Overall, the data processing strategy is not suitable for real time guidance/management of many medical diseases/conditions such as tolerance and rejection monitoring in organ transplant recipients, etc. Considering the routine use of the NGS-based diagnostic and prognostic in clinical setting, the need for the fast turnaround time, easy operation and accurate NGS-based data analysis platform has become prominent.
In this study, we assessed the performance of the world's first bioinformatics processor DRAGEN Bio-IT Processor [10] [11] which is designed to analyze the NGS data. The DRAGEN (Dynamic Read Analysis for Genomics) Processor uses a field-programmable gate array (FPGA), implemented on a PCIe card embedded in a pre-configured server, to provide hardware-accelerated implementations of genome pipeline algorithms, such as BCL conversion, compression, mapping, alignment, sorting, duplicate marking and haplotype variant calling.
This study was carried out in two steps. First, run time performance of the DRAGEN Bio-IT Genome pipelines with the most commonly used GATK's best-practice guidelines were analyzed for the 2 replicates of NA12878 Whole Genome Sequencing (WGS) dataset. Second, the variant calling efficiencies of the two pipelines were evaluated by comparing variants with the GIABv2.19 high confidence (truth) call-set [12] [13] . These studies demonstrate that the employment of the DRAGEN Bio-IT processor decreased the WGS NGS-data analysis time to just ~40 minute while achieving the equivalent or better genotype variant calling accuracy than the standard GATK Best Practices workflow.
Methods

Sequence Data-Set and GIAB Validation Call-Set
Two WGS replicates of the Coriell Cell Repository NA12878 reference sample NA12878 were downloaded from the Garvan NA12878 HiSeqX datasets [18] .
These datasets have been sequenced on the Illumina HiSeq X platform using the Illumina's TruSeq Nano kit using 350 bp inserts. Each dataset contains over 120 GB of fastq data yield, with > 87% bases with quality > Q30. These replicates are sequenced to assess the reproducibility and has been provided freely for research purpose by the The Garvan Institute of Medical Research, DNA nexus and AllSeq.
As a gold standard practice to validate the variant calling platform's performance, the high confidence reference variant calls for the 1000 Genome project individual (sample NA12878), published by the Genome in a Bottle (GIAB) consortium [12] 
GATK Best Practices Workflow
GATK Best Practices workflow is used most commonly to analyze the genomic data. The complete best practice pipeline [19] can be basically divided into two phase. First, preprocessing the raw data which includes, alignment the raw fastq data to the hg19 reference genome using mapping by BWA (version 0.7.12-r1039) [20] , sorting by samtools (version 1.2 using htslib 1.2.1) [21] , MarkDuplicate and addRG by steps using picard-tools (version 1.119), and Base Recalibration using GATK (version 3.6-0-g89b7209) [19] . Second, Variants calling using GATK HaplotypeCaller. This study followed the GATK best practice workflow recommended commands and arguments at each step which were executed on 48 core (using-nt and -nct arguments) the Intel Xeon E5-2697v2 12C server with 2.7 GHz processors,128 GB RAM and 3.2 TB capacity SSD running on CentOS 6.6.
DRAGEN Bio-IT Processor and DRAGEN Genome Pipelines
Unlike the traditional Genome analysis workflows, DRAGEN Bio-IT processor is the hardware accelerated platform which comes equipped with a custom Pe- 
Performance Assessment of the Two Variant Calling Pipelines
This study utilized below mentioned two WGS data analysis pipelines to process the dataset consist of two replicate of the NA12878. respectively, were used to assess the consistency and reproducibility of the variant calling workflows. GIAB high confidence truth-set, along with the high confidence genomic region bed file, was used to assessed the performance of the both variant calling pipelines and suggest the best pipeline to the NGS-based researcher. More details about the sequence dataset and validation call-set can be found in Method section.
Runtime Performance of the Genome Analysis Pipelines
One of the main object of this study is the Run-time assessment of the DRAGEN against the GATK Best Practice pipelines. Run time matrices were divided into, mapping time (i.e. fastq to Bam file generation time) and variant calling time (Bam to VCF generation). Table 1 lists the run time matrices for both the pipelines. DRAGEN alignment includes the sorting, duplicate marking, ReadGroup information adding, etc. GATK best practice pipeline includes the mapping by BWA and preprocessing by samtools, Picard-tools, GATK, etc. All the command utilized the multithreaded option with maximum of 48 core, except the Picard-tools which utilized single core. Calling (Bam2VCF) and complete pipeline run (FastQ2VCF), is listed.
As listed in Table 1 
Variant Calling Accuracy of the WGS Variant Calling Pipelines
Variant calling accuracy of the two pipelines were assessed against the standard GIAB high confidence region truth-set (v2.19). For this, both the WGS data analysis pipelines were executed for the two replicates of NA12878 WGS data. For each pipeline, a high-confident subset of variants, in the GIAB high confidence genome region (bed file), were selected and compared with the GIAB truth-set to calculate the sensitivity, specificity and accuracy of each pipelines.
Both the pipelines showed ~99% and ~90% variant calling sensitivities for SNPs and INDELs, respectively while maintaining over 98% detection specificity in both the cases. As listed in Table 2 and shown in Figure 3 , DRAGEN Genome pipelines showed slightly higher SNP detection accuracy than GATK best 
Discussion
The major focus on the NGS-data analysis workflow is how to speed-up the analysis time without sacrificing the variant calling accuracy to utilize the NGSbased diagnosis more effectively, especially in a real-time disease management, NA12878 WGS using default software parameters and a single 16-core server (allowing 32 threads) with 128 GB of RAM. Even though, this study doesn't compare the DRAGEN Genome pipeline's speed and accuracy with such pipelines, but ~40 minutes WGS data analysis time is much less than above mentioned pipelines which makes the DRAGEN system highly promising at industrial scale.
One important observation in our study is that DRAGEN Genome Pipelines is highly sensitive at low False Positive Rate. As shown in ROC curve of SNPs and
INDELs for WGS dataset in the Figure 4 , with the increase in the variant calling sensitivity (over 92% for SNPs and over 80% for INDEL case) the false positive hits increased significantly which reduces the overall DRAGEN variant callers' accuracy. For example, as shown in Table 2 Altogether, this study focused on demonstrating the proficiency and comparison of DRAGEN Bio-IT software and DRAGEN Genome Pipelines with tradi-tional approaches. These results implicate that the DRAGEN system can be used
as a single platform to analyze the genomic data accurately in quicker time at industrial scale. We expect, this research will help the scientist to make an informed choice to set-up a new (or modify the existing) genome analysis platform in their laboratory and/or institute.
